The North America biobanking market size was valued at USD 1.1 billion in 2024, driven by the rising prevalence of chronic diseases and the growing demand for effective treatments in the region. The market is expected to grow at a CAGR of 6.31% during the forecast period of 2025-2034, with the values likely to rise from USD 1.2 billion in 2025 to USD 2 billion by 2034. Biobanks play a crucial...